Rising to the Top: How Immune-Checkpoint Inhibitors are Changing the Landscape of Treatment for Classic Hodgkin LymphomaImmune checkpoint inhibitors have transformed the future management of classic Hodgkin lymphoma (CHL) in the frontline and salvage settings. Both nivolumab and pembrolizumab have high ...
Figure 1. How we incorporate novel agents into treatment of classical Hodgkin lymphoma. Acknowledgments The authors thank Philippe Armand for his thoughtful review of the manuscript. A.F.H. is supported by the Emmet and Toni Stephenson Leukemia and Lymphoma Society Scholar Award and the Lymphoma Re...
Classical Hodgkin's lymphoma (cHL) is an unusual lymphoid neoplasm, and nearly 50% of patients still relapse after standard therapy. Programmed cell death protein 1 (PD-1) signaling plays a vital in the progression of cHL. Anti-PD-1 antibodies such as nivolumab and pembrolizumab have thus bee...
rituximab, as the first anti-tumor targeted drug, was approved for non-Hodgkin lymphoma. It wasn't until a decade later, in 2007, that sorafenib became the first targeted drug approved by the U.S. Food and Drug Administration (FDA) for HCC and was recommended as the...
The successful treatment of Hodgkin's lymphoma is one of the most impressive achievements of modern medicine. Today more than 90 % of patients without fever, weight loss, or night sweats (B symptoms) are cured with optimal treatment, and 60–70 % of those with B symptoms are cured as ...
Understand the basics of lymphoma, the differences between Hodgkin and non-Hodgkin lymphoma, and why some people may be more susceptible to this type of cancer. Your doctor can help you find the right treatment for your type and stage of the illness. Lymphoma is different from leukemia. Each...
depending on the type and stage of the illness. Understand the basics of lymphoma, the differences between Hodgkin and non-Hodgkin lymphoma, and why some people may be more susceptible to this type of cancer. Your doctor can help you find the right treatment for your type and stage of the...
Comparing the UK & US Approaches to First-Line Treatment in Hodgkin Lymphoma This is a modal window. The Playback API request failed for an unknown reason Error Code: VIDEO_CLOUD_ERR_UNKNOWN Technical details : Unknown catalog request error. Session ID: 2025-04-14:34fa49946c63baaedf214...
The successful treatment of Hodgkin lymphoma is one of the most impressive achievements of modern medicine. Today more than 90% of patients without fever, weight loss, or night sweats (B symptoms) are cured with optimal treatment, and 60–70% of those wi
depending on the type and stage of the illness. Understand the basics of lymphoma, the differences between Hodgkin and non-Hodgkin lymphoma, and why some people may be more susceptible to this type of cancer. Your doctor can help you find the right treatment for your type and stage of the...